ID
MJN

Integral Derivatives’s Mead Johnson Nutrition Company MJN Stock Holding History

Integral Derivatives’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-35,100
Closed -$3.13M – 1383
2017
Q1 		$3.13M Sell
35,100
-3,400
-9% -$280K 0.06% 215
2016
Q4 		$2.72M Buy
38,500
+30,700
+394% +$2.29M 0.05% 246
2016
Q3 		$616K Sell
7,800
-7,800
-50% -$665K 0.01% 569
2016
Q2 		$1.42M Sell
15,600
-700
-4% -$59.3K 0.03% 312
2016
Q1 		$1.39M Buy
16,300
+6,300
+63% +$469K 0.05% 300
2015
Q4 		$790K Buy
+10,000
New +$788K 0.02% 538
2015
Q1 		– Sell
-3,100
Closed -$312K – 1535
2014
Q4 		$312K Sell
3,100
-1,900
-38% -$189K 0.01% 1065
2014
Q3 		$481K Buy
+5,000
New +$474K 0.01% 989
2014
Q2 		– Sell
-41,800
Closed -$3.48M – 1604
2014
Q1 		$3.48M Buy
41,800
+16,800
+67% +$1.36M 0.07% 263
2013
Q4 		$2.09M Buy
+25,000
New +$2.04M 0.03% 471

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Integral Derivatives's MJN Position: Q2 2017 in Review

Integral Derivatives sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 23,864 shares — an estimated $2.13M sold.

Integral Derivatives first reported a position in MJN in Q1 2014 and held it in 7 quarters. The position peaked at $2.13M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Integral Derivatives reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Integral Derivatives sold 23,864 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $2.13M.
  • Integral Derivatives first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 7 quarters.
  • Integral Derivatives's Mead Johnson Nutrition Company position peaked at $2.13M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.